Patent application number | Description | Published |
20100179575 | Adjustable sacral mesh fixation device and method - A sacral mesh fixation device and method of use for sacral colpopexy. The sacral mesh fixation device comprises multiple hinged sections pivoted together at opposite ends and adapted to clamp one or more strips of sacral mesh there between. A latching mechanism is provided for releasably latching the opposing sections shut, thereby releasably clamping the sacral mesh to allow verification of tension. A sequential latching mechanism is provided to fixedly lock the fixation device to the sacral mesh by latching the remaining section to the prior sections. At least one of the sections may be sutured to tissue and the sacral mesh inserted between the sections and releasably clamped in place, thereby releasably affixing the mesh to the tissue or fixedly locking the mesh to the device thereby permanently locking the mesh to the tissue. To use the device, a single mesh fixation device or a plurality of mesh fixation devices may be introduced through a trocar into the abdomen, positioned in a single or supporting array, and sutured to surrounding tissue. The sacral mesh is then clamped between opposing sections of the mesh fixation device(s), thereby temporarily suspending the mesh in a sling. However, the fixation devices can be reopened to facilitate easy readjustment and repositioning of the mesh sling to achieve the proper tension and position or fixedly locked for permanent support of the mesh. | 07-15-2010 |
20100191248 | ARTHROSCOPIC TUNNEL GUIDE FOR ROTATOR CUFF REPAIR - A drill guide assembly for drilling a tunnel having a fixed, non-zero radius of curvature, where the drill guide assembly includes a housing and a sleeve, or cutting tube, configured to reciprocate within the distal portion where the sleeve, or cutting tube, is configured to receive a bone cutting instrument. | 07-29-2010 |
20110174313 | ENDOSCOPIC MESH DELIVERY SYSTEM WITH INTEGRAL MESH STABILIZER AND VAGINAL PROBE - A mesh delivery system for sacral colpopexy procedures is disclosed. The system uses a mesh stabilizer ( | 07-21-2011 |
20140018610 | ENDOSCOPIC MESH DELIVERY SYSTEM WITH INTEGRAL MESH STABILIZER AND VAGINAL PROBE - A mesh delivery system for sacral colpopexy and other procedures involving surgical mesh is disclosed. The system uses a mesh stabilizer ( | 01-16-2014 |
20140330203 | AUTO-INJECTOR - Provided is a cassette unit suitable for use with an auto-injector having an electrically powered drive unit. The cassette unit has a housing defining a cassette unit housing cavity and a needle projection aperture. The cassette unit housing cavity is arranged for receipt of a syringe. The syringe has a barrel for containing a volume of a liquid drug formulation, the barrel defining a flange at the rear end thereof and a forward shoulder at the forward end thereof; a hollow needle at a front end of the barrel, the hollow needle defining a needle tip; and a plunger that is axially movable within the barrel. The cassette unit includes, in contact with the plunger and axially movable within the barrel, a plunger slaving part arranged such that when a drive load is applied to a rear drive-receiving face thereof the drive load is evenly transmitted to the plunger. | 11-06-2014 |
20140330207 | AUTO-INJECTOR - Provided is a cassette unit suitable for use with an auto-injector having an electrically powered drive unit. The cassette unit has a housing defining a cassette unit housing cavity and a needle projection aperture. The cassette unit housing cavity is arranged for receipt of a syringe suitable for use in the injected delivery of drug to a patient. The cassette unit includes a needle cover defining a needle sheath. The removable cap is provided with a connector defining one or more needle cover gripping elements for gripping the needle cover. The connector defines a central hub and the one or more needle gripper elements attach to the central hub and in spaced arrangement relative to each other. The connector locates within the removable cap such that the central hub of the connector is in spaced relationship with a far end wall or surface of the cap interior. | 11-06-2014 |
20140336587 | AUTO-INJECTOR - Provided is a cassette unit suitable for use with an auto-injector having an electrically powered drive unit. The cassette unit has a housing defining a cassette unit housing cavity and a needle projection aperture. The housing cavity is arranged for receipt of a syringe suitable for use in the injected delivery of drug to a patient. The syringe has a barrel for containing a volume of a liquid drug formulation, the barrel defining an end flange at the rear end thereof and a forward shoulder at the forward end thereof. The cassette unit includes a sleeve form adapter arranged for receipt by the syringe barrel and to fit at least partly over the end flange of the syringe barrel. Accommodation of different syringe sizes within the same cassette unit geometry is achievable by selecting a sleeve form adapter tailored to the particular sizing of the barrel of each different syringe. | 11-13-2014 |
20140336588 | AUTO-INJECTOR - Provided is a cassette unit suitable for use with an auto-injector having an electrically powered drive unit. The cassette unit has a housing defining a cassette unit housing cavity and a needle projection aperture. The housing cavity is arranged for receipt of a syringe for injected delivery of a drug to a patient. The cassette unit includes a removable cap that in a capping position fits over and thereby acts to close off the needle projection aperture; and connecting to the removable cap, a needle cover defining a needle sheath for sheathing the needle tip of the syringe. The removable cap is provided with one or more first engagement features arranged for selectively engaging one or more second engagement features of the cassette unit housing when the removable cap is in the capping position to thereby restrict/prevent rotation of the removable cap and needle cover relative to the housing. | 11-13-2014 |
20140358084 | AUTO-INJECTOR - There is provided a cassette unit that is suitable for use with an auto-injector having an electrically powered drive unit. The cassette unit has a housing defining a cassette unit housing cavity and a needle projection aperture. The cassette unit housing cavity is arranged for receipt of a syringe that is suitable for use in the injected delivery of drug to a patient. The cassette unit includes a removable cap that in a capping position fits over and thereby, acts such as to close off, the needle projection aperture. The cassette unit includes a cap lock feature movable from a first cap locking position in which it prevents removal of the removable cap from the capping position with the cassette unit to a second cap non-locking position in which it no longer prevents such cap removal. | 12-04-2014 |
20150020637 | Table-Mounted Surgical Instrument Stabilizers - A surgical instrument stabilizer system that includes an articulating boom that is releasably connectable to a surgical table side rail. The articulating boom includes an actuator, a multi-directional flexible arm having a first end region attached to the actuator, and a cable extending through the flexible arm. The cable has one end region connected to the actuator and another end region connected to a preload tensioning mechanism. The actuator is operable to tighten and loosen the cable, and the preload tensioning mechanism maintains an amount of tension in the cable when the actuator loosens the cable. The system further includes a surgical instrument-supporting member that is attached to a second end region of the flexible arm and is configured to releasably retain a surgical instrument. | 01-22-2015 |
20150045734 | AUTO-INJECTOR - Provided is a cassette unit suitable for use with an auto-injector having an electrically powered drive unit. The cassette unit has a housing defining a cassette unit housing cavity and a needle projection aperture. The housing cavity is arranged for receipt of a syringe suitable for delivery of a drug to a patient. The syringe has a barrel for containing a volume of a liquid drug formulation, the barrel defining a flange at the rear end thereof and a forward shoulder at the forward end thereof. The cassette unit includes one or more shoulder support features for supporting the forward shoulder of the syringe. In use, the one or more shoulder support features act to direct a major part of an applied load path to travel through the shoulder at the forward end of the syringe and lesser load to pass through the flange at the rear end thereof. | 02-12-2015 |
20150051442 | ENDOSCOPIC MESH DELIVERY SYSTEM WITH INTEGRAL MESH STABILIZER AND VAGINAL PROBE - A mesh delivery system for sacral colpopexy procedures is disclosed. The system uses a mesh stabilizer that is introduced in a compressed configuration through a surgical port into the abdomen, and a vaginal probe (inserted through the vagina) with a magnetic or non-magnetic head that engages with the mesh stabilizer, anchoring it in position. The mesh stabilizer employs a pseudoelastic shape memory alloy, and folds compact to deliver multiple mesh straps or a single Y-shaped surgical mesh in a streamlined configuration into the abdomen for facilitating the sacral colpopexy procedure. After delivery, the stabilizer expands to a functional configuration where it interfaces with the probe head and stabilizes and adjustably feeds the mesh strap(s) for suturing while maintaining stabilization of the mesh on the vaginal apex and while keeping excess mesh from obscuring the surgeons view. After suturing, the stabilizer can be removed back through the surgical port. | 02-19-2015 |
20160128308 | Hummingbird Feeder and Feed Pod - A hummingbird feeder that is easier to maintain and reduces food spoilage includes a feed pod support adapted to hold a hummingbird feed pod that proportionally resembles the thickening part of the stem of an actual-size flower, a flower top or cover for the pod, an elongated stem that is attached to the feed pod support, a ‘feeding’ perch adapted to provide a hummingbird with a place to rest while extending its beak through a feeding hole in the flower top, a ‘high’ perch to provide a hummingbird with a place to perch while not feeding, and wherein the feed pod can be either of the type that allows for a single-use or, with refilling, multiple uses. | 05-12-2016 |
Patent application number | Description | Published |
20100160314 | Small Molecule Inhibitors of Toll-Like Receptor 9 - Small molecule compounds and compositions containing said compounds useful for inhibiting signaling by certain Toll-like receptors (TLRs), particularly TLR9, are provided. The compounds and compositions can be used to inhibit immune responses, including unwanted immune responses in particular. Compounds, compositions, and methods are provided to treat a variety of conditions involving unwanted immune responses, including for example autoimmune disease, inflammation, transplant rejection, and sepsis. | 06-24-2010 |
20100303850 | NANOCARRIERS POSSESSING COMPONENTS WITH DIFFERENT RATES OF RELEASE - This invention relates to compositions, and related methods, of synthetic nanocarriers that comprise immunomodulatory agents and antigens that are differentially released from the synthetic nanocarriers. | 12-02-2010 |
20100316659 | IMMUNOSTIMULATORY OLIGORIBONUCLEOTIDES - The invention provides immunostimulatory compositions and use of those compounds in the preparation of medicaments for the treatment of disease as well as in vitro uses. In particular, the compositions of the invention include immunostimulatory oligoribonucleotides that incorporate a sequence-dependent immunostimulatory sequence motif. Specific modifications involving phosphate linkages, nucleotide analogs, adducts, and combinations thereof are provided. Compositions of the invention, which optionally can include an antigen, can be used alone or together with other treatments to stimulate or enhance an immune response. Also provided are compositions and methods useful for treating a subject having an infection, a cancer, an allergic condition, asthma, airway remodeling, or immunodeficiency. Immunostimulatory oligoribonucleotides of the invention are believed to stimulate Toll-like receptor 8 (TLR8). | 12-16-2010 |
20110020388 | TARGETED SYNTHETIC NANOCARRIERS WITH PH SENSITIVE RELEASE OF IMMUNOMODULATORY AGENTS - This invention relates to compositions, and related methods, of synthetic nanocarriers that target sites of action in cells, such as antigen presenting cells (APCs), and comprise immunomodulatory agents that dissociate from the synthetic nanocarriers in a pH sensitive manner. Also disclosed are compositions and methods relating to synthetic nanocarriers that encapsulate labile immunomodulatory agents that dissociate from the synthetic nanocarriers in a pH sensitive manner. | 01-27-2011 |
20110027217 | IMMUNOMODULATORY AGENT-POLYMERIC COMPOUNDS - This invention relates to compositions, and related compounds and methods, of conjugates of immunomodulatory agents and polymers or unit(s) thereof. The conjugates may be contained within synthetic nanocarriers, and the immunomodulatory agents may be released from the synthetic nanocarriers in a pH sensitive manner. | 02-03-2011 |
20110110965 | COMPOSITIONS THAT INDUCE T CELL HELP - The present invention relates, at least in part, to compositions, and related methods, comprising MHC II binding peptides. In one embodiment, the MHC II binding peptides comprise a peptide having at least 70% identity to a natural HLA-DP binding peptide, HLA-DQ binding peptide, or HLA-DR binding peptide. | 05-12-2011 |
20110171248 | SYNTHETIC VIRUS-LIKE PARTICLES CONJUGATED TO HUMAN PAPILLOMAVIRUS CAPSID PEPTIDES FOR USE AS VACCINES - Disclosed are compositions and related methods that involve a synthetic nanocarrier that includes at least one peptide obtained from Human papillomavirus L1 or L2 capsid protein; wherein the peptide is coupled to an external surface of the synthetic nanocarrier. | 07-14-2011 |
20110206719 | IMMUNOSTIMULATORY OLIGORIBONUCLEOTIDES - The invention provides immunostimulatory compositions and use of those compounds in the preparation of medicaments for the treatment of disease as well as in vitro uses. In particular, the compositions of the invention include immunostimulatory oligoribonucleotides that incorporate a sequence-dependent immunostimulatory sequence motif. Specific modifications involving phosphate linkages, nucleotide analogs, adducts, and combinations thereof are provided. Compositions of the invention, which optionally can include an antigen, can be used alone or together with other treatments to stimulate or enhance an immune response. Also provided are compositions and methods useful for treating a subject having an infection, a cancer, an allergic condition, asthma, airway remodeling, or immunodeficiency. Immunostimulatory oligoribonucleotides of the invention are believed to stimulate Toll-like receptor 8 (TLR8). | 08-25-2011 |
20110223201 | Immunonanotherapeutics Providing a Th1-Biased Response - Disclosed are synthetic nanocarrier compositions, and related methods, for treating diseases in which generating a Th1-biased immune response is desirable. | 09-15-2011 |
20110244025 | MODIFIED OLIGORIBONUCLEOTIDE ANALOGS WITH ENHANCED IMMUNOSTIMULATORY ACTIVITY - The invention provides immunostimulatory compositions and methods for their use. In particular, the immunostimulatory compositions of the invention include RNA-like polymers that incorporate an immunostimulatory sequence motif and at least one chemical modification to confer improved stability against nuclease degradation and improved activity. Specific modifications involving phosphate linkages, nucleotide analogs, and combinations thereof are provided. Compositions of the invention optionally include an antigen and can be used to stimulate an immune response. Also provided are compositions and methods useful for treating a subject having an infection, a cancer, an to allergic condition, or asthma. Modified oligoribonucleotide analogs of the invention are believed to stimulate Toll-like receptors TLR7 and TLR8. | 10-06-2011 |
20110293700 | NANOCARRIER COMPOSITIONS WITH UNCOUPLED ADJUVANT - Disclosed are synthetic nanocarrier compositions with separate adjuvant compositions as well as related methods. | 12-01-2011 |
20110293701 | MULTIVALENT SYNTHETIC NANOCARRIER VACCINES - The invention relates, at least in part, to compositions comprising populations of synthetic nanocarriers that comprise different sets of antigens as well as related methods. | 12-01-2011 |
20110293723 | SYNTHETIC NANOCARRIER COMBINATION VACCINES - Disclosed are dosage forms and related methods, that include a first population of synthetic nanocarriers that have one or more first antigens coupled to them, one or more second antigens that are not coupled to the synthetic nanocarriers, and a pharmaceutically acceptable excipient. | 12-01-2011 |
20110300164 | IMMUNOSTIMULATORY DNA:RNA OLIGONUCLEOTIDES - Immunostimulatory sequence-specific RNA oligonucleotides corresponding to 3′ terminal sequences of single-stranded minus-sense RNA genomic RNAs are provided. Also provided are compositions and methods relating to an immunostimulatory 4-mer RNA motif provided as 5′-C/U-U-G/U-U-3′. Incorporation of this short RNA motif is sufficient to confer new and altered immunostimulatory properties in new and existing oligonucleotides, including CpG oligodeoxynucleotides. Also provided are methods for use of the immunostimulatory RNA oligonucleotides and DNA:RNA chimeric oligonucleotides of the invention to induce an immune response in vitro and in vivo, as well as to treat allergy, asthma, infection, and cancer in a subject. Single-stranded oligoribonucleotides of the invention are believed to signal through a Toll-like receptor (TLR) chosen from TLR9, TLR8, TLR7, and TLR3. The oligoribonucleotides can also be used in a method to screen for TLR antagonists. | 12-08-2011 |
20120027806 | DOSE SELECTION OF ADJUVANTED SYNTHETIC NANOCARRIERS - Disclosed are synthetic nanocarrier compositions with coupled adjuvant compositions as well as related methods. | 02-02-2012 |
20120058153 | SYNTHETIC NANOCARRIER VACCINES COMPRISING PROTEINS OBTAINED OR DERIVED FROM HUMAN INFLUENZA A VIRUS HEMAGGLUTININ - This invention relates to compositions and methods that can be used immunize a subject against influenza. Generally, the compositions and methods include polypeptides obtained or derived from human influenza A virus hemagglutinin. | 03-08-2012 |
20120058154 | SYNTHETIC NANOCARRIER VACCINES COMPRISING PEPTIDES OBTAINED OR DERIVED FROM HUMAN INFLUENZA A VIRUS M2E - This invention relates to compositions and methods that can be used immunize a subject against influenza. Generally, the compositions and methods include peptides obtained or derived from human influenza A virus M2 protein. | 03-08-2012 |
20120064110 | SYNTHETIC NANOCARRIER VACCINES COMPRISING PEPTIDES OBTAINED OR DERIVED FROM HUMAN INFLUENZA A VIRUS HEMAGGLUTININ - This invention relates to compositions and methods that can be used immunize a subject against influenza. Generally, the compositions and methods include peptides obtained or derived from human influenza A virus hemagglutinin. | 03-15-2012 |
20120070493 | TARGETED MULTI-EPITOPE DOSAGE FORMS FOR INDUCTION OF AN IMMUNE RESPONSE TO ANTIGENS - Provided herein are compositions and methods related to MHC II binding peptides. In some embodiments, the peptides are obtained or derived from a common source. In other embodiment, the peptides are obtained or derived from an infectious agent to which a subject has been repeatedly exposed. | 03-22-2012 |
20120177701 | COMPOSITIONS COMPRISING IMMUNOSTIMULATORY NUCLEIC ACIDS AND RELATED METHODS - Immunostimulatory compositions include an isolated nucleic acid molecule that includes one or more nucleotide sequences from 5′- or 3′-terminal regions of positive-sense, single-stranded RNA virus genomes and/or or nucleotide sequences from a 5′-terminal regions of negative-sense, single-stranded RNA virus genomes. | 07-12-2012 |
20120213812 | Immunostimulatory Oligonucleotides - Compositions that include immunostimulatory nucleic acids are disclosed, along with the use of such compositions to induce immune responses. | 08-23-2012 |
20120276159 | TOLEROGENIC SYNTHETIC NANOCARRIERS - This invention relates, at least in part, to compositions comprising synthetic nanocarriers and immunosuppressants that result in immune suppressive effects. Such compositions can further comprise antigen and provide antigen-specific tolerogenic immune responses. | 11-01-2012 |
20140030344 | TARGETED SYNTHETIC NANOCARRIERS WITH PH SENSITIVE RELEASE OF IMMUNOSTIMULATORY AGENTS - This invention relates to compositions, and related methods, of synthetic nanocarriers that target sites of action in cells, such as antigen presenting cells (APCs), and comprise immunomodulatory agents that dissociate from the synthetic nanocarriers in a pH sensitive manner. Also disclosed are compositions and methods relating to synthetic nanocarriers that encapsulate labile immunomodulatory agents that dissociate from the synthetic nanocarriers in a pH sensitive manner. | 01-30-2014 |
20140079724 | NOVEL IMMUNE SYSTEM MODULATORS - The present invention relates to a compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same; and a method for treating or preventing autoimmunity disease using the same. | 03-20-2014 |
20140107115 | NOVEL IMMUNE SYSTEM MODULATORS - The present invention relates to a compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same; and a method for treating or preventing autoimmunity disease using the same. | 04-17-2014 |
20140135487 | IMMUNOSTIMULATORY G, U-CONTAINING OLIGORIBONUCLEOTIDES - Compositions and methods relating to immunostimulatory RNA oligomers are provided. The immunostimulatory RNA molecules are believed to represent natural ligands of one or more Toll-like receptors, including Toll-like receptor 7 (TLR7) and Toll-like receptor 8 (TLR8). The compositions and methods are useful for stimulating immune activation. Methods useful for screening candidate immunostimulatory compounds are also provided. | 05-15-2014 |
20140193453 | IMMUNOMODULATORY AGENT-POLYMERIC COMPOUNDS - This invention relates to compositions, and related compounds and methods, of conjugates of immunomodulatory agents and polymers or unit(s) thereof. The conjugates may be contained within synthetic nanocarriers, and the immunomodulatory agents may be released from the synthetic nanocarriers in a pH sensitive manner. | 07-10-2014 |
20140221646 | NOVEL IMMUNE SYSTEM MODULATORS - The present invention relates to a compound of Formula I: | 08-07-2014 |
20140242121 | NOVEL IMIDAZOLE QUINOLINE-BASED IMMUNE SYSTEM MODULATORS - The present invention relates to a compound of Formula I: or an enantiomer, diastereomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same; and a method for treating or preventing autoimmunity disease using the same. | 08-28-2014 |
20140242173 | TARGETED SYNTHETIC NANOCARRIERS WITH PH SENSITIVE RELEASE OF IMMUNOMODULATORY AGENTS - This invention relates to compositions, and related methods, of synthetic nanocarriers that target sites of action in cells, such as antigen presenting cells (APCs), and comprise immunomodulatory agents that dissociate from the synthetic nanocarriers in a pH sensitive manner. Also disclosed are compositions and methods relating to synthetic nanocarriers that encapsulate labile immunomodulatory agents that dissociate from the synthetic nanocarriers in a pH sensitive manner. | 08-28-2014 |
20150328300 | IMMUNOMODULATORY AGENT-POLYMERIC COMPOUNDS - This invention relates to compositions, and related compounds and methods, of conjugates of immunomodulatory agents and polymers or unit(s) thereof. The conjugates may be contained within synthetic nanocarriers, and the immunomodulatory agents may be released from the synthetic nanocarriers in a pH sensitive manner. | 11-19-2015 |
20150328309 | DOSE SELECTION OF ADJUVANTED SYNTHETIC NANOCARRIERS - Disclosed are synthetic nanocarrier compositions with coupled adjuvant compositions as well as related methods. | 11-19-2015 |
20150328333 | TOLEROGENIC SYNTHETIC NANOCARRIERS - This invention relates, at least in part, to compositions comprising synthetic nanocarriers and immunosuppressants that result in immune suppressive effects. Such compositions can further comprise antigen and provide antigen-specific tolerogenic immune responses. | 11-19-2015 |
20160074403 | NOVEL IMMUNE SYSTEM MODULATORS - The present invention relates to a compound of Formula I: | 03-17-2016 |
Patent application number | Description | Published |
20080305554 | Automated yield monitoring and control - A system is adapted to automatically maintain a desired yield level for a slurry flow. Measurements of the electrical conductivity of a slurry are taken and corrected for the effects of temperature and pressure. The corrected conductivity measurements are used to arrive at a value for system yield. The system automatically determines if the yield is too high or too low relative to a desired level, and controls the rate at which accelerator is added to the slurry in order to increase or decrease yield. | 12-11-2008 |
20100152749 | Table-mounted surgical instrument stabilizers with single-handed or voice activated maneuverability - A surgical instrument stabilizer system for securely holding virtually any instrument during any procedure, delivering vacuum when applicable, and yet allowing easy single-handed or voice activated repositioning by a user. The system utilizes opposing horizontal side-rails mounted to opposing sides of a surgical table, and opposing arms each slidably mounted on a side rail for global lengthwise positioning along the side rails. The arms carry a transverse beam at the foot of the operating table, and a flexible arm is movably mounted on the beam for global lengthwise positioning along the beam. Alternately, the flexible arm may be affixed directly to one of the existing horizontal side rails. The flexible arm leads to an instrument-supporting hand piece pivotally mounted for angular orientation of an instrument supported thereby. The flexible arm can be freely articulated to any position and locked in place. Thus, a supported instrument can be repositioned quickly and easily by single-handed or voice activated manipulation by a surgeon or surgical assistant, and locked in any position up and down along a vertical axis, forward and back, i.e, toward or away from the patient, and rotationally. | 06-17-2010 |
20100179575 | Adjustable sacral mesh fixation device and method - A sacral mesh fixation device and method of use for sacral colpopexy. The sacral mesh fixation device comprises multiple hinged sections pivoted together at opposite ends and adapted to clamp one or more strips of sacral mesh there between. A latching mechanism is provided for releasably latching the opposing sections shut, thereby releasably clamping the sacral mesh to allow verification of tension. A sequential latching mechanism is provided to fixedly lock the fixation device to the sacral mesh by latching the remaining section to the prior sections. At least one of the sections may be sutured to tissue and the sacral mesh inserted between the sections and releasably clamped in place, thereby releasably affixing the mesh to the tissue or fixedly locking the mesh to the device thereby permanently locking the mesh to the tissue. To use the device, a single mesh fixation device or a plurality of mesh fixation devices may be introduced through a trocar into the abdomen, positioned in a single or supporting array, and sutured to surrounding tissue. The sacral mesh is then clamped between opposing sections of the mesh fixation device(s), thereby temporarily suspending the mesh in a sling. However, the fixation devices can be reopened to facilitate easy readjustment and repositioning of the mesh sling to achieve the proper tension and position or fixedly locked for permanent support of the mesh. | 07-15-2010 |
20110174313 | ENDOSCOPIC MESH DELIVERY SYSTEM WITH INTEGRAL MESH STABILIZER AND VAGINAL PROBE - A mesh delivery system for sacral colpopexy procedures is disclosed. The system uses a mesh stabilizer ( | 07-21-2011 |
20120180872 | AUTOMATED YIELD MONITORING AND CONTROL - A system is adapted to automatically maintain a desired yield level for a slurry flow. Measurements of the electrical conductivity of a slurry are taken and corrected for the effects of temperature and pressure. The corrected conductivity measurements are used to arrive at a value for system yield. The system automatically determines if the yield is too high or too low relative to a desired level, and controls the rate at which accelerator is added to the slurry in order to increase or decrease yield. | 07-19-2012 |
20140018610 | ENDOSCOPIC MESH DELIVERY SYSTEM WITH INTEGRAL MESH STABILIZER AND VAGINAL PROBE - A mesh delivery system for sacral colpopexy and other procedures involving surgical mesh is disclosed. The system uses a mesh stabilizer ( | 01-16-2014 |
20140358084 | AUTO-INJECTOR - There is provided a cassette unit that is suitable for use with an auto-injector having an electrically powered drive unit. The cassette unit has a housing defining a cassette unit housing cavity and a needle projection aperture. The cassette unit housing cavity is arranged for receipt of a syringe that is suitable for use in the injected delivery of drug to a patient. The cassette unit includes a removable cap that in a capping position fits over and thereby, acts such as to close off, the needle projection aperture. The cassette unit includes a cap lock feature movable from a first cap locking position in which it prevents removal of the removable cap from the capping position with the cassette unit to a second cap non-locking position in which it no longer prevents such cap removal. | 12-04-2014 |
20140358085 | AUTO-INJECTOR - There is provided a cassette unit that is suitable for use with an auto-injector having an electrically powered drive unit. The cassette unit has a housing defining a cassette unit housing cavity and a needle projection aperture. The cassette unit housing cavity is arranged for receipt of a syringe that is suitable for use in the injected delivery of drug to a patient. The cassette unit includes a removable cap that fits over and thereby, acts such as to close off the needle projection aperture; and connecting to the removable cap, a needle cover defining a needle sheath for sheathing of the needle tip of the syringe. The removable cap is provided with a finger-grip feature that is sized and shaped for gripping by the finger of a user to allow for removal of the removable cap and needle cover from the cassette unit housing. | 12-04-2014 |
20160128308 | Hummingbird Feeder and Feed Pod - A hummingbird feeder that is easier to maintain and reduces food spoilage includes a feed pod support adapted to hold a hummingbird feed pod that proportionally resembles the thickening part of the stem of an actual-size flower, a flower top or cover for the pod, an elongated stem that is attached to the feed pod support, a ‘feeding’ perch adapted to provide a hummingbird with a place to rest while extending its beak through a feeding hole in the flower top, a ‘high’ perch to provide a hummingbird with a place to perch while not feeding, and wherein the feed pod can be either of the type that allows for a single-use or, with refilling, multiple uses. | 05-12-2016 |
Patent application number | Description | Published |
20080212503 | Method and System for Tailoring WiMAX Device Provisioning Based on Device Capability Information Communicated to Network - Before a WiMAX-equipped device is distributed to an end-user, the manufacturer or distributor of the WiMAX-equipped device will record in the device a set of data that describes characteristics (e.g., type, features, capabilities, and limitations) of the device. When the end-user powers on the device or otherwise brings the device within the coverage of a service provider's WiMAX base station, the device will then acquire radio connectivity, typically with the service provider authenticating the device's WiMAX chipset. Thereafter, the device will engage in a first-time activation/service-provisioning session with a system operated by the service provider, and during that session, the device will provide the system with its device-characteristics data and the service provider will use that device-characteristics data as a basis to customize provisioning of service for the device based on the device's features and capabilities. | 09-04-2008 |
20090268655 | Method and system for controlling the provision of media content to mobile stations - A media service controller controls how one or more base stations transmit media content from one or more media servers to mobile stations. The media service controller may control whether a mobile station receives media content via a unicast or a multicast connection, e.g., based on a predefined schedule and/or on whether other mobile stations served by the same base station are receiving the same media content. The media service controller may provide a content discovery service through which a first media server may determine whether other media servers are providing the same media content. The media service controller may facilitate changing a source of media content received by a mobile station, e.g., by changing the source from a first media server to a second media server when the mobile station moves from an area associated with the first media server to an area associated with the second media server. | 10-29-2009 |
20120008534 | Method and System for Tailoring Wireless Device Service Provisioning Based on Device Capability Information Communicated to Network - Before a wireless-equipped device is distributed to an end-user, the manufacturer or distributor of the wireless-equipped device will record in the device a set of data that describes characteristics (e.g., type, features, capabilities, and limitations) of the device. When the end-user powers on the device or otherwise brings the device within the coverage of a service provider's wireless base station, the device will then acquire radio connectivity, typically with the service provider authenticating the device's wireless chipset. Thereafter, the device will engage in a first-time activation/service-provisioning session with a system operated by the service provider, and during that session, the device will provide the system with its device-characteristics data and the service provider will use that device-characteristics data as a basis to customize provisioning of service for the device based on one or more of the device's features or capabilities. | 01-12-2012 |
20120275372 | Method and System for Controlling the Provision of Media Content to Mobile Stations - A media service controller controls how one or more base stations transmit media content from one or more media servers to mobile stations. The media service controller may control whether a mobile station receives media content via a unicast or a multicast connection, e.g., based on a predefined schedule and/or on whether other mobile stations served by the same base station are receiving the same media content. The media service controller may provide a content discovery service through which a first media server may determine whether other media servers are providing the same media content. The media service controller may facilitate changing a source of media content received by a mobile station, e.g., by changing the source from a first media server to a second media server when the mobile station moves from an area associated with the first media server to an area associated with the second media server. | 11-01-2012 |
20130279415 | Method For Transmitting Streaming Media Content To Wireless Subscriber Stations Using Packet Header Suppression - A radio access system receives packets from a local source of streaming media content via a local connection and from remote packet sources via a remote network. The radio access system communicates with a subscriber station via an air interface that includes an uplink and a downlink. A packet classifier in the radio access system maps packets having the subscriber station's IP address as destination address to the subscriber station's downlink. The subscriber station communicates with a content controller via the remote network to request selected streaming media content. The content controller instructs the radio access system to convey the selected streaming media content from the local source to the subscriber station. In response, the packet classifier maps the packets containing the selected streaming media content to a downlink (either the original downlink or a new one) for transmission to the subscriber station. | 10-24-2013 |
20130281006 | System For Transmitting Streaming Media Content To Wireless Subscriber Stations - A radio access system receives packets from a local source of streaming media content via a local connection and from remote packet sources via a remote network. The radio access system communicates with a subscriber station via an air interface that includes an uplink and a downlink. A packet classifier in the radio access system maps packets having the subscriber station's IP address as destination address to the subscriber station's downlink. The subscriber station communicates with a content controller via the remote network to request selected streaming media content. The content controller instructs the radio access system to convey the selected streaming media content from the local source to the subscriber station. In response, the packet classifier maps the packets containing the selected streaming media content to a downlink (either the original downlink or a new one) for transmission to the subscriber station. | 10-24-2013 |